Adding analysis of FURIN to the diagnostic gene panel for aneurysm, will identify a larger group of aneurysm patients and families who may develop a complex vascular phenotype based on TGF-β dysregulation, and these patients may need corresponding clinical management. This evidence concerns the gene TGFB1 and aneurysm.